Evidence map›Paper›PMID 40240143›Full record

ArticleGenes & development2025

Histone chaperones coupled to DNA replication and transcription control divergent chromatin elements to maintain cell fate.

Reuben Franklin, Brian Zhang, Jonah Frazier, Meijuan Chen, Brian T Do, Sally Padayao, Kun Wu, Matthew G Vander Heiden, Christopher R Vakoc, Jae-Seok Roe and 4 more

Abstract read
In one paragraph

Article in Genes & development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Reuben Franklin *Department of Biochemistry, University of California Riverside, Riverside, California 92521, USA.ORCID 0000-0002-6513-3205
Brian Zhang *Department of Biochemistry, University of California Riverside, Riverside, California 92521, USA.ORCID 0009-0009-2657-5367
Jonah FrazierDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.
Meijuan ChenDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.
Brian T DoKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
Sally PadayaoDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.
Kun WuDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.
Matthew G Vander HeidenKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.ORCID 0000-0002-6702-4192
Christopher R VakocCold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.ORCID 0000-0002-1158-7180
Jae-Seok RoeDepartment of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, South Korea.ORCID 0000-0002-9994-3062
Maria NinovaDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.ORCID 0000-0001-5051-5502
Jernej MurnDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA.ORCID 0000-0002-1729-5859
David B SykesCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Sihem CheloufiDepartment of Biochemistry, University of California Riverside, Riverside, California 92521, USA; sihem.cheloufi@ucr.edu.ORCID 0000-0002-1726-4796

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI David A Tuveson · 1987 to 2026
$118.9M
Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Melanie Funes · 1994 to 2026
$57.9M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Understanding the role of metabolism in cancerR35CA242379 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2019 to 2025
$5.8M
Targeting aberrant enhancer landscapes in pancreatic cancerR01CA229699 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Christopher Vakoc · 2019 to 2026
$3.3M
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemiaR01CA281106 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Christopher Vakoc, Yan Jessie Zhang · 2023 to 2026
$2.9M
Investigating the molecular mechanisms of early neuronal morphogenesisR01GM144693 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Jernej Murn · 2022 to 2026
$1.7M
Investigating the Molecular Basis of Transposon Regulation and Function in Animal DevelopmentR35GM151016 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Maria Antoninova NINOVA · 2023 to 2026
$1.6M
Investigating the Regulatory Roles of Histone Chaperones in Cellular PlasticityR35GM151004 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI Sihem Cheloufi · 2023 to 2026
$1.6M
Elucidating the role of SUMO ligase Su(var)2-10 in piRNA-guided transcriptional silencing and repressive chromatin formationR00HD099316 · NICHD · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI NINOVA, MARIA ANTONINOVA · 2021 to 2023
$712k
PacBio RS Single Molecule, Real-Time (SMRT) DNA SequencerS10OD010794 · OD · UNIVERSITY OF CALIFORNIA-IRVINE · PI SANDMEYER, SUZANNE · 2012 to 2012
$600k
High-Throughput DNA SequencerS10OD021718 · OD · UNIVERSITY OF CALIFORNIA-IRVINE · PI SANDMEYER, SUZANNE · 2016 to 2016
$600k
NCI NIH HHS P30 CA045508NCI NIH HHS P30 CA062203NCI NIH HHS R01 CA229699NCI NIH HHS R01 CA281106NCI NIH HHS R35 CA242379NCRR NIH HHS S10 RR025496NHLBI NIH HHS F30 HL156404NICHD NIH HHS R00 HD099316NIGMS NIH HHS R01 GM144693NIGMS NIH HHS R35 GM151004NIGMS NIH HHS R35 GM151016NIGMS NIH HHS T32 GM144273NIH HHS S10 OD010794NIH HHS S10 OD021718
6 · The paper itself

Abstract

The manipulation of DNA replication and transcription can be harnessed to control cell fate. Central to the regulation of these DNA-templated processes are histone chaperones, which in turn are emerging as cell fate regulators. Histone chaperones are a group of proteins with diverse functions that are primarily involved in escorting histones to assemble nucleosomes and maintain the chromatin landscape. Whether distinct histone chaperone pathways control cell fate and whether they function using related mechanisms remain unclear. To address this, we performed a screen to assess the requirement of diverse histone chaperones in the self-renewal of hematopoietic stem and progenitor cells. Remarkably, all candidates were required to maintain cell fate to differing extents, with no clear correlation with their specific histone partners or DNA-templated process. Among all the histone chaperones, the loss of the transcription-coupled histone chaperone SPT6 most strongly promoted differentiation, even more than the major replication-coupled chromatin assembly factor complex CAF-1. To directly compare how DNA replication- and transcription-coupled histone chaperones maintain stem cell self-renewal, we generated an isogenic dual-inducible system to perturb each pathway individually. We found that SPT6 and CAF-1 perturbations required cell division to induce differentiation but had distinct effects on cell cycle progression, chromatin accessibility, and lineage choice. CAF-1 depletion led to S-phase accumulation, increased heterochromatic accessibility (particularly at H3K27me3 sites), and aberrant multilineage gene expression. In contrast, SPT6 loss triggered cell cycle arrest, altered accessibility at promoter elements, and drove lineage-specific differentiation, which is in part influenced by AP-1 transcription factors. Thus, CAF-1 and SPT6 histone chaperones maintain cell fate through distinct mechanisms, highlighting how different chromatin assembly pathways can be leveraged to alter cell fate.

Indexed as

Cell DifferentiationChromatinDNA ReplicationHistone ChaperonesTranscription, GeneticAnimalsHematopoietic Stem CellsHistonesHumansTranscriptional Elongation FactorsChromatinHistone ChaperonesHistonesTranscriptional Elongation FactorsDNA replicationhistone chaperoneslineage choicestem cellstranscriptiontranscription factors

Identifiers

PMID40240143
PMCPMC12047658

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.